5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

被引：0
|
作者：
Kohno, Takeya [1 ]
Yamamoto, Manabu [1 ]
Tamachi, Tomoko [1 ]
Asai, Jyunji [1 ]
Oishi, Natsuko [1 ]
Ataka, Shinsuke [1 ]
Yasui, Ayako [1 ]
Cho, Akira [2 ]
Hirabayashi, Michiko [2 ]
Shiraki, Kunihiko [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Ophthalmol & Visual Sci, Osaka, Japan
[2] Shiraniwa Hosp, Ikoma, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
880
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
    Taiichi Hikichi
    Hirokuni Kitamei
    Shoko Shioya
    BMC Ophthalmology, 16
  • [32] Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab
    C S Tan
    W K Ngo
    L W Lim
    T H Lim
    Eye, 2015, 29 : 1238 - 1238
  • [33] Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
    Hikichi, Taiichi
    BMC OPHTHALMOLOGY, 2015, 15
  • [34] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    Wang, Jia-Kang
    APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
  • [35] Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
    Taiichi Hikichi
    BMC Ophthalmology, 15
  • [36] Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
    Chhablani, Jay Kumar
    Narula, Ritesh
    Narayanan, Raja
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (03) : 136 - U63
  • [37] Nine-year treatment outcome of naive polypoidal choroidal vasculopathy in clinical practice
    Jung, Byung Ju
    Lee, Won Ki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis
    Liu, Lei
    Tham, Yih-Chung
    Wu, Jingyang
    Yue, Song
    Cheng, Ching-Yu
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2017, 20 : 215 - 220
  • [39] Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    Lee, Zeon
    Haruyama, Miho
    Akaza, Eriko
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (09) : 1233 - 1239
  • [40] Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
    Chhablani, Jay Kumar
    Narula, Ritesh
    Narayanan, Raja
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2014, 62 (01) : 97 - 97
12345